Verapamil acute administration: A new dynamic test in hyperprolactinemic states

Metabolism: Clinical and Experimental

Volumn 48, Issue 11, 1999, Pages 1351-1356

  Barbaro, Daniele ^a,b   Faggionato, Ferdinando ^a   Pallini, Stefania ^a   Carnesecchi, Carlo ^a   Palla, Adriana ^a   Bombara, Maria ^a   Falciani, Carlo ^a   La Gioia, Antonio ^a   Loni, Giorgio ^a  

^a Unita Operativa Neurochirurgia   (Italy)

^b 2 Med Generale Endocrinologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPERPROLACTINEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA;

EID: 0032725981     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90142-7     Document Type: Article

References (21)

1. Schlecte H, Sherman B, Halmi N, et al: Prolactin-secreting pituitary tumors in amenorrheic women. A comprehensive study. Endocr Rev 1:295, 1980
2. Camanni F, Ciccarelli E, Ghigo E, et al: Hyperprolactinemia: Neuroendocrine and diagnostic aspect. J Endocrinol Invest 12:653-668, 1989
3. Blackwell RE: Hyperprolactinemia. Evaluation and management. Endocrinol Metab Clin North Am 21:105-124, 1992
4. Massara F, Genazzani AR, Camanni F, et al: Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: Nomifensine and domperidone. Fertil Steril 35:149, 1981
5. Thorner MO, Hackett JT, Murad F, et al: Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release. Neuroendocrinology 31:390-402, 1980
6. De Marinis L, Mancini A, Minnielli S, et al: Calcium antagonists and hormone release. Horm Res 25:5-12, 1987
7. Knoepfelmacher M, Villares SM, Nicolau W, et al: Calcium and prolactin secretion in humans: Effect of channel blocker, verapamil, in the spontaneous and drug-induced hyperprolactinemia. Horm Metab Res 26:481-485, 1994
8. Nielsen Kudsk JE, Bartels PD, Dalby J: Effects of verapamil on diurnal and thyrotropin-releasing hormone stimulated prolactin levels in man. J Clin Endocrinol Metab 70:1269-1272, 1990
9. Kelley SR, Kamal TJ, Molitch ME: Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia. Am J Physiol 270:E96-E100, 1996
10. Colao A, Di Sarno A, Sarnacchiaro F, et al: Effect of verapamil administration in tumoral and non-tumoral hyperprolactinemic states. J Endocrinol Invest, vol 19, 1996 (suppl, abstr)
11. Barbara D, Bassano G, Busoni A, et al: Verapamil acute administration in hyperprolactinemic states: A useful diagnostic tool. J Endocrinol Invest, vol 20, 1997 (suppl, abstr)
12. Ozawa S, Kimura N: Calcium channel and prolactin release in rat clonal pituitary cells: Effect of verapamil. Am J Physiol 243:E68-E73, 1982
13. 2+ entry blockers on dopamine induced inhibition of in vitro prolactin secretion. Eur J Pharmacol 146:201-206, 1988
14. Gregerson KA, Chucknyiska R, Gelesorkhi N: Stimulation of prolactin release by dopamine withdrawal: Role of calcium influx. Am J Physiol 267:E789-E794, 1994
15. Law GJ, Pachter JA, Danniers PS: Calcium transients induced by TRH rapidly lose their ability to cause release of prolactin. Mol Endocrinol 3:539-546, 1989
16. Haisenleder DJ, Yasin M, Marshall JC: Regulation of prolactin, thyrotropin subunit and gonadotropin subunit gene expression by pulsatile or continuous calcium signals. Endocrinology 133:2055-2061, 1993
17. Laverries JN, Tixier-Vidai A, Buisson N, et al: Preferential role of calcium in the regulation of prolactin gene transcription by TRH in GH3 pituitary cells. Endocrinology 122:333-340, 1988
18. Enyeart JJ, Biagi B, Day RN: Opposing actions of Bay K 8644 enantiomers on calcium current prolactin secretion and synthesis in pituitary cells. Mol Endocrinol 4:727-735, 1990
19. Douglas PZ: Management of cardiac arrhythmias: Pharmacological, electrical, and surgical techniques, in Braunwald E (ed): Heart Disease. A Textbook of Cardiovascular Medicine (ed 3). Philadelphia, PA, Saunders, 1988, pp 621-657
20. Kates RE, Keefe DL, Schwartz J, et al: Verapamil disposition kinetics in chronic atrial fibrillation. Clin Pharmacol Ther 30:44, 1981
21. Molitch ME, Russell EJ: The pituitary "incidentaloma." Ann Intern Med 112:925-931, 1990